当前位置: 首页 > 期刊 > 《中国医学创新》 > 202016
编号:13473129
贝伐珠单抗胸腔灌注联合用药治疗恶性胸腔积液的研究进展(5)
http://www.100md.com 2020年6月5日 《中国医学创新》 202016
     [15] Duzkopru Y,Oruf Z,Kaplan M A,et al.The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion[J].Contemp Oncol (Pozn),2017,21(3):213-217.

    [16] Chen D W,Song X Y,Shi F,et al.Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effuion[J].Oncotarget ......
上一页1 2 3 4 5 6下一页

您现在查看是摘要页,全文长 3085 字符